Calamos Advisors Lowers stake in Acadia Healthcare Company Inc (ACHC)

Acadia Healthcare Company Inc (ACHC) : Calamos Advisors reduced its stake in Acadia Healthcare Company Inc by 10.97% during the most recent quarter end. The investment management company now holds a total of 1,083,710 shares of Acadia Healthcare Company Inc which is valued at $55,583,486 after selling 133,535 shares in Acadia Healthcare Company Inc , the firm said in a disclosure report filed with the SEC on Jul 26, 2016.Acadia Healthcare Company Inc makes up approximately 0.50% of Calamos Advisors’s portfolio.

Other Hedge Funds, Including , Strs Ohio sold out all of its stake in ACHC during the most recent quarter. The investment firm sold 55,000 shares of ACHC which is valued $2,820,950.Huntington National Bank boosted its stake in ACHC in the latest quarter, The investment management firm added 784 additional shares and now holds a total of 843 shares of Acadia Healthcare Company Inc which is valued at $43,237.Ibm Retirement Fund boosted its stake in ACHC in the latest quarter, The investment management firm added 1,311 additional shares and now holds a total of 7,359 shares of Acadia Healthcare Company Inc which is valued at $401,066. Acadia Healthcare Company Inc makes up approx 0.01% of Ibm Retirement Fund’s portfolio.Cutler Group Lp boosted its stake in ACHC in the latest quarter, The investment management firm added 59,097 additional shares and now holds a total of 62,767 shares of Acadia Healthcare Company Inc which is valued at $3,541,942. Acadia Healthcare Company Inc makes up approx 0.24% of Cutler Group Lp’s portfolio.

Acadia Healthcare Company Inc opened for trading at $51.69 and hit $57.29 on the upside on Friday, eventually ending the session at $56.5, with a gain of 6.02% or 3.21 points. The heightened volatility saw the trading volume jump to 22,04,883 shares. Company has a market cap of $4,940 M.

On the company’s financial health, Acadia Healthcare Company Inc reported $0.73 EPS for the quarter, based on the information available during the earnings call on Jul 29, 2016. Analyst had a consensus estimate of $0.73. The company had revenue of $756.55 million for the quarter, compared to analysts expectations of $754.90 million. The company’s revenue was up 66.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.57 EPS.

Many Wall Street Analysts have commented on Acadia Healthcare Company Inc. Shares were Reiterated by RBC Capital Mkts on Aug 1, 2016 to “Outperform” and Lowered the Price Target to $ 78 from a previous price target of $86 .Company shares were Reiterated by Mizuho on Apr 29, 2016 to “Buy”, Firm has raised the Price Target to $ 71 from a previous price target of $66 .

Acadia Healthcare Company Inc. is a provider of behavioral healthcare services. The Company develops and operates inpatient psychiatric facilities residential treatment centers group homes substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities. It operates in two segments: U.S. Facilities and U.K. Facilities. Its U.S. Facilities and services are classified into categories which includes acute inpatient psychiatric facilities; specialty treatment facilities; residential treatment centers; and outpatient community-based services. In the United Kingdom it provides inpatient services through mental health hospitals and care homes. In addition to these services it also operates a U.K. division to provide EAP to organizations. The Company operated approximately 78 behavioral healthcare facilities with over 5800 beds in approximately 24 states the United Kingdom and Puerto Rico.

Leave a Reply

Acadia Healthcare Company Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Acadia Healthcare Company Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.